| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |